As the commercial arm of the European Cancer Network, daCRO provides rapid or accelerated oncology patient recruitment services for Pharma-sponsored clinical trials in the EU and UK
can provide you with a complete dedicated patient recruitment service.
can work with you as a patient accelerator for poorly recruiting studies in Europe.
provides consulting services around feasibility, clinical trial / protocol design, and cancer network navigation.
daCRO acts as the EU gateway for patient recruitment to new cancer drug development in Europe.
We use the entire Cancer Network to provide patient access that's never been done before by operating a competitive recruitment program for oncology patients that are vital to clinical trial success.
Have experience to run the planned study.
Have local, certified laboratory facility capable of performing all exams described in the protocol.
See sufficient patients who meet eligibility criteria.
Are able to enrol patients on time.
Have no current/planned research studies with the same target population that would compete.